A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.

Item
http://www.wikidata.org/entity/Q33416075
New and emerging developments in extensive-stage small cell lung cancer therapeuticsSrc inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status.Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer.Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.The importance of Src signaling in sarcoma.Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell linesThe next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.What's new in small cell lung cancer - extensive disease? An overview on advances of systemic treatment in 2016.Targeting metastasis.The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancer.Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.c-Src activity is differentially required by cancer cell motility modes.Targeting the intracellular signaling "STOP" and "GO" pathways for the treatment of alcohol use disorders.
P2860

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.

Item
http://www.wikidata.org/entity/Q33416075
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase II trial of the Src-ki ...... ng cancer: NCCTG trial N-0621.
@ast
A phase II trial of the Src-ki ...... ng cancer: NCCTG trial N-0621.
@en
type
label
A phase II trial of the Src-ki ...... ng cancer: NCCTG trial N-0621.
@ast
A phase II trial of the Src-ki ...... ng cancer: NCCTG trial N-0621.
@en
prefLabel
A phase II trial of the Src-ki ...... ng cancer: NCCTG trial N-0621.
@ast
A phase II trial of the Src-ki ...... ng cancer: NCCTG trial N-0621.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A phase II trial of the Src-ki ...... ng cancer: NCCTG trial N-0621.
@en
P2093
P2860
P304
P31
P356
10.1016/J.LUNGCAN.2014.03.004
P433
P478
P577
P5875
P698
P921
P932